Chapter 3.11 “Variations and extensions”: Inclusion of no. A.3.11.0.8
Chapter 2.5.6 Explanations regarding the documentation of Environmental Risk Assessments (ERA) for biosimilar applications and additional indications that are likely to have a substantial environmental impact.
The modified guidance document takes immediate effect.